Popliteal artery entrapment syndrome occupies a frustrating corner of vascular medicine. It overwhelmingly affects young, physically active people — the demographic that doctors tend to reassure first and investigate last.

Living with tibial torsion — whether you discovered it as a child whose feet turned inward, as a teenager with unexplained knee pain, or as an adult who finally connected the dots between gait mechanics and chronic joint stress — means navigating a condition that rarely gets the attention it deserves.

If you are a runner, cyclist, or military athlete who feels a building pressure, burning, or numbness in your lower legs during exercise — symptoms that vanish within minutes of stopping and return every time you push past a certain threshold — you are already familiar with how difficult this experience is to explain.

If you are taking a statin and experiencing unexplained muscle pain, weakness, or fatigue, you are not imagining it. Statin-induced myopathy affects an estimated 5 to 10 percent of patients on standard doses and up to 25 percent at higher doses, yet it remains one of the most underrecognized and poorly managed side effects in cardiovascular care.